Our services

Growth capital with healthcare expertise built in.

We invest between €5 million and €40 million in established healthcare and technology companies, as minority or majority shareholders, and support them with sector-specific know-how.

Explore our services
Laboratory research in progress
What we offer

Six ways we help healthcare companies grow.

Every investment combines capital with practical support. Choose an area below to arrange a confidential consultation with the relevant partner.

Pharmaceutical growth capitalPharmaceuticals

Pharmaceutical growth capital

Minority and majority growth investments in specialty pharma, CDMOs and consumer health companies that already have commercial traction and need capital to scale manufacturing, registrations and international distribution.

  • Capacity expansion and GMP upgrades
  • Portfolio in-licensing and market access
  • European and international roll-out
Book a consultation
Medical devices & diagnosticsMedical devices

Medical devices & diagnostics

Capital and hands-on support for MedTech companies with CE-marked or FDA-cleared products, helping them move from early adoption to broad clinical use while meeting MDR and IVDR requirements.

  • Regulatory and quality system scaling
  • Commercial team and distributor build-out
  • Reimbursement and health-economics strategy
Book a consultation
Healthcare softwareHealth software

Healthcare software

Growth equity for SaaS and digital health platforms serving hospitals, clinics, payers and life sciences companies, with a focus on recurring revenue, clinical integration and product-led expansion.

  • Go-to-market and pricing architecture
  • Interoperability and security certification
  • Buy-and-build across European markets
Book a consultation
Health data & analyticsHealth data

Health data & analytics

Investments in companies that turn real-world evidence, clinical and operational data into better decisions, always grounded in GDPR compliance, data ethics and certified hosting.

  • Real-world evidence and data partnerships
  • HDS and GDPR compliance frameworks
  • AI governance and model validation
Book a consultation
Strategic value creationValue creation

Strategic value creation

Beyond capital, we co-build a 100-day plan and multi-year roadmap with management, covering organisation, pricing, operations and international expansion.

  • Board-level strategic guidance
  • Senior hiring and governance design
  • KPI and reporting frameworks
Book a consultation
Acquisitions & consolidationBuy-and-build

Acquisitions & consolidation

We help platform companies identify, evaluate and integrate complementary businesses to accelerate their footprint, capabilities and product portfolio.

  • Target mapping and outreach
  • Due diligence and deal structuring
  • Post-merger integration support
Book a consultation
Clinician using medical technology
Investment criteria

The companies we are looking for.

  • Revenue typically between €5 million and €100 million
  • Proven product with regulatory clearance or strong commercial traction
  • Headquartered in Europe, with international ambitions
  • Committed management team seeking a long-term partner
Submit your project
Health analytics dashboard
Investment structures

Flexible structures for different stages.

We adapt to the needs of founders and existing shareholders, whether the goal is to accelerate organic growth, provide partial liquidity or prepare for a transformative acquisition.

  • Primary growth capital and secondary share purchases
  • Minority positions with tailored governance rights
  • Majority investments and management buy-outs
Key benefits

What partnering with us brings.

Faster scaling

Capital deployed against a clear plan to reach new markets and customers sooner.

Regulatory readiness

Support preparing for audits, certifications and market-access submissions.

Industry network

Introductions to hospitals, pharma partners, distributors and senior talent.

Data trust

Best practice in cybersecurity, GDPR and health-data hosting.

Operational excellence

Proven playbooks for pricing, sales efficiency and supply chain.

Exit preparation

Structured preparation for a strategic sale, secondary or IPO when the time is right.

How we work

A clear, respectful investment process.

First conversation

An introductory call to understand your company, ambitions and funding needs.

Assessment

Review of key information under NDA and a preliminary indication of interest.

Due diligence

Focused commercial, regulatory, technical and financial diligence with your team.

Partnership

Closing, followed by a jointly built value-creation plan and ongoing support.

Ready to discuss your growth plans?

Book a confidential consultation with the partner responsible for your sector.

Start a conversation